NovoCure Ltd - NVCR
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 26, 2026 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Soleus Capital Master Fund, L.P. | 7.6% | 8,530,665 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Soleus Capital, LLC | 7.6% | 8,530,665 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Soleus Capital Group, LLC | 7.6% | 8,530,665 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Soleus Capital Management, L.P. | 7.6% | 8,530,665 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Soleus GP, LLC | 7.6% | 8,530,665 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Guy Levy | 7.6% | 8,530,665 | View |
| Nov 13, 2025 | SCHEDULE 13G/A | Capital World Investors | 1.8% | 2,000,000 | View |
| Nov 07, 2025 | SCHEDULE 13G/A | Soleus Capital Master Fund, L.P. | 8.6% | 9,644,872 | View |
| Nov 07, 2025 | SCHEDULE 13G/A | Soleus Capital, LLC | 8.6% | 9,644,872 | View |
| Nov 07, 2025 | SCHEDULE 13G/A | Soleus Capital Group, LLC | 8.6% | 9,644,872 | View |
| Nov 07, 2025 | SCHEDULE 13G/A | Soleus Capital Management, L.P. | 8.6% | 9,644,872 | View |
| Nov 07, 2025 | SCHEDULE 13G/A | Soleus GP, LLC | 8.6% | 9,644,872 | View |
| Nov 07, 2025 | SCHEDULE 13G/A | Guy Levy | 8.6% | 9,644,872 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.